跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40 条关于
“JuvNET”
全部
40
临床试验
17
药物
2
机构
2
资讯
19
上个月
Juvena Therapeutics Appoints Julie Anne Smith as CEO as JUV-161 Advances Through Phase 2a
去年
Juvena Therapeutics Initiates First-in-Human Trial of JUV-161 for Muscle Regeneration in Myotonic Dystrophy
去年
Juvena Therapeutics Partners with Eli Lilly in AI-Driven Muscle Health Drug Discovery Collaboration
8个月前
Juvena Therapeutics Secures $33.5M Series B to Advance AI-Enabled Regenerative Biologics Pipeline
9个月前
Long-Term JULIET Trial Data Shows CAR-T Therapy Delivers Durable Survival in Relapsed B-Cell Lymphoma
去年
Unicycive's Hyperphosphatemia Drug, Oxylanthanum Carbonate, Awaits FDA Decision in June
2年前
FDA Approves First Bispecific T-Cell Engager for Solid Tumors and Expands Indications for Immunotherapies
10个月前
Five-Year JULIET Trial Data Confirms Tisagenlecleucel as Curative CAR-T Therapy for Relapsed/Refractory Large B-Cell Lymphoma
去年
Moderna Schedules Investor Conference Presentations for May and June 2025
2年前
Qlife's Egoo Health Platform Shows Promise in PKU Monitoring and CRP Testing Amidst Restructuring
第 1 页,共 2 页
上一页
下一页